Brief: NeuBase Therapeutics Reports Financial Results For The First Quarter Of Fiscal Year 2021
11/02/2021 21:06
Feb 11 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE
FIRST
QUARTER OF FISCAL YEAR 2021
* Q1 LOSS PER SHARE $0.18
* Q1 EARNINGS PER SHARE ESTIMATE $-0.23 -- REFINITIV IBES
DATA
* NEUBASE THERAPEUTICS - ESTIMATES CASH AND CASH EQUIVALENTS
ARE
SUFFICIENT TO FUND CURRENTLY PLANNED OPERATING & CAPITAL
EXPENDITURES INTO Q1 OF CY2022
Source text for Eikon: ID:nGNX2CT4mK
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet